Brain signature of resilience suggests a new way to recovery from trauma

Researchers at UCSF find a brain signature of resilience in mice that suggests a new way of treating severe depression.

Scientists identify over 5,000 genetic variants that enable certain cancers to thrive

Researchers performed saturation genome editing of the BAP1, whose dysfunction is related to cancer and impaired neurodevelopment.

July 10, 2024

Pfizer, Arvinas’ breast cancer drug combo keeps momentum after Phase 1b update

Pfizer and Arvinas’ targeted protein degrader plus Ibrance has shown promising efficacy in breast cancer patients in updated data from an early-stage trial, raising anticipation

May 17, 2024

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD – Psychedelic Alpha

In two weeks’ time, the FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) will meet to discuss Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application (NDA).

May 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.